Blood flow restriction versus standard physical therapy after ankle ligament reconstruction
Evaluating the Efficacy of Blood Flow Restriction Therapy in a Randomized Clinical Trial for Postoperative Rehabilitation Following Ankle Ligament Reconstruction
This project will test whether adding blood flow restriction (BFR) to regular physical therapy helps adults recovering from ankle ligament reconstruction regain muscle and function faster.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 105 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Texas Tech University Health Sciences Center Academic / other |
| Locations | 5 sites (Lubbock, Texas and 4 other locations) |
| Trial ID | NCT07451210 on ClinicalTrials.gov |
What this trial studies
This randomized, single-blinded trial compares standard physical therapy (SoC) to physical therapy with blood flow restriction (BFR) for patients after ankle ligament reconstruction. Participants receive a minimum of six weeks of supervised physical therapy delivered by certified therapists, with outcome measures taken at the start and at the end of the therapy period. Key outcomes include muscle atrophy (circumference), strength and fatigability via manual muscle testing, ankle function using the FADI, pain using a visual analog scale, and resting cardiovascular measures. The study is conducted at participating sites in Lubbock, Texas.
Who should consider this trial
Good fit: Adults aged 18–65 who have had ankle ligament reconstruction and can attend and pay for or have insurance coverage for at least six weeks of physical therapy, and who do not have major cardiac, clotting, autoimmune, neurologic, pregnancy, cancer, or worker's compensation exclusions.
Not a fit: Patients with major cardiac or connective tissue disorders, clotting problems or recent DVT/stroke, autoimmune disease, pregnancy, active cancer, professional athletes, or those on worker's compensation are excluded and unlikely to derive benefit from participation.
Why it matters
Potential benefit: If successful, adding BFR could speed muscle recovery, reduce pain, and improve ankle function after reconstruction.
How similar studies have performed: Smaller orthopedic rehabilitation studies of BFR have shown promising gains in muscle size and strength, but high-quality evidence specifically after ankle ligament reconstruction is limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18-65 years. 2. Post ankle ligament reconstruction surgery (medial or lateral, with or without ankle scope). 3. Capability of paying for physical therapy or having insurance coverage for at least 6 weeks of therapy. Exclusion Criteria: 1. Major cardiac or connective tissue disorders (e.g., Ehlers-Danlos syndrome, Marfan syndrome). 2. Autoimmune disorders. 3. History of stroke or deep vein thrombosis (DVT). 4. Bleeding or coagulation disorders. 5. Congenital or developmental musculoskeletal disorders (e.g., cerebral palsy, Parkinson's disease). 6. Pregnancy (current or planning to become pregnant in the next 4 months) 7. Malignancy (cancer). 8. Professional athletes. 9. Workers compensation insurance status as worker's compensation often does not cover the necessary duration of physical therapy (minimum of 4 weeks). 10. Be currently enrolled or have been enrolled in another interventional clinical research study within the past 30 days (at time of consent); or 11. Be deemed unsuitable for inclusion in the study at the discretion of the Investigators 12. Cognitively not able to consent or participate in research (dementia; severe developmental delay; language/communication limitations; brain injury; etc.)
Where this trial is running
Lubbock, Texas and 4 other locations
- Physical Therapy Today (PTT) — Lubbock, Texas, United States (Active_not_recruiting)
- University Medical Center — Lubbock, Texas, United States (Active_not_recruiting)
- Northstar Surgery Center — Lubbock, Texas, United States (Active_not_recruiting)
- The Center for Orthopedic Surgery — Lubbock, Texas, United States (Recruiting)
- Texas Tech University Health Sciences Center — Lubbock, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Jerry Grimes, MD — Texas Tech University Health Sciences Center
- Study coordinator: Jenny Hudnall, MS BME
- Email: jennifer.hudnall@ttuhsc.edu
- Phone: 806-743-2260
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.